Abby Chopoorian Fuchsman

Abby Chopoorian Fuchsman

Auto-generated profile, based on publicly available information

Abby Chopoorian Fuchsman

Division of Plastic and Reconstructive Surgery, Weill Cornell Medicine, New York, NY, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAbby Chopoorian
Abby Chopoorian
PBPadmapriya Banada
Padmapriya Banada
RRRobert Reiss
Robert Reiss
DEDavid Elson
David Elson
SDSamuel Desind
Samuel Desind
YXYingda L Xie
Yingda L Xie
Saliva has been a COVID-19 diagnostic specimen of interest due to its simple collection, scalability, and yield. Yet COVID-19 testing and estimates of the infectious period remain largely based on nasopharyngeal and nasal swabs. We sought to evaluate whether saliva testing captured prolonged presence of SARS-CoV-2 and potential infectiousness later in the disease course. We conducted an observational study of symptomatic COVID-19 patients at University Hospital in Newark, NJ. Paired saliva and nasal specimens from 96 patients were analyzed, including longitudinal analysis of paired observations from 28 of these patients who had multiple time-points. Saliva detected significantly more cases of COVID-19 beyond 5 days (86.1% [99/115] saliva vs 48.7% [56/115] nasal, p-value < 0.001), 9 days (79.4% [50/63] saliva vs 36.5% [23/63] nasal, p-value < 0.001) and 14 days (71.4% [20/28] saliva vs 32.1% [9/28] nasal, p-value = 0.010) of symptoms. Additionally, saliva yielded lower cycle thresholds across all time periods, indicative of higher viral loads in saliva. In the longitudinal analysis, a log-rank analysis indicated that the survival curve for saliva was significantly different from the curve for nasal swabs (p<0.001) with a median survival time for saliva of 18 days compared to 13 days for nasal swabs. We additionally performed saliva viral cultures among a similar COVID-19 patient cohort and noted patients with positive saliva viral cultures between 7 to 28 days of symptoms. Findings from this study suggest that SARS-CoV-2 RNA persists longer and in higher abundance in saliva compared to nasal swabs, with potential of prolonged propagating virus. Testing saliva may thus increase yield for detecting potentially infectious virus even beyond the first five days of symptomatic COVID-19.

17 April 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
KMKate Manley
Kate Manley
SSSophia Salingaros
Sophia Salingaros
AFAbby Chopoorian Fuchsman
Abby Chopoorian Fuchsman
XDXue Dong
Xue Dong
JSJason A. Spector
Jason A. Spector